BioHarvest Sciences Inc. operates as a biotechnology company in Israel and the United States. It operates through two segments: Products and CDMO Services. The company develops botanical synthesis platform technology to produce plant cells with higher concentrations of active ingredients. It is involved in the research, development, manufacturing, marketing, and sale of science-based health and wellness nutraceutical solutions that are manufactured and sold as dietary supplements and functional food and beverages, as well as the manufacturing, marketing, and sale of science-based health, pharmaceutical, and cosmeceutical solutions. The company also provides contract development and manufacturing operation services. Further, it offers VINIA, a red grape cell dietary supplement containing the matrix of polyphenols contained in red wine. The company has a strategic collaboration with Tate & Lyle plc for the development of plant-based sweetener molecules. The company is based in Vancouver, Canada.
Frequently asked questions
What sector does BioHarvest Sciences Inc. Common Stock (BHST) operate in?
BioHarvest Sciences Inc. Common Stock belongs to the Consumer Staples sector and operates in the Packaged Foods industry.
What is BioHarvest Sciences Inc. Common Stock (BHST) current stock price?
As of the latest data, BioHarvest Sciences Inc. Common Stock stock price is $2.17, with a previous close of $2.07. BioHarvest Sciences Inc. Common Stock gained $0.10 in the last trading session, representing a 4.83% increase.
What is BioHarvest Sciences Inc. Common Stock (BHST) current market capitalization?
BioHarvest Sciences Inc. Common Stock market cap is approximately 49.19 million.
What is BioHarvest Sciences Inc. Common Stock (BHST) Earnings Per Share (EPS)?
The trailing EPS is -$0.51, and the forward EPS is -$0.34.
What is BioHarvest Sciences Inc. Common Stock (BHST) EBITDA?
BioHarvest Sciences Inc. Common Stock EBITDA (Earnings Before Interest, Taxes, Depreciation, and Amortization) is -2.02 million.
Does BioHarvest Sciences Inc. Common Stock (BHST) pay dividends?
No. BioHarvest Sciences Inc. Common Stock does not pay a dividend.
How did BioHarvest Sciences Inc. Common Stock (BHST) perform in its most recent earnings report?
In the last report (June 30, 2026), BioHarvest Sciences Inc. Common Stock posted an EPS surprise of -30.77% and a revenue surprise of -6.5%.
What is BioHarvest Sciences Inc. Common Stock (BHST) beta (volatility) score?
BioHarvest Sciences Inc. Common Stock has a beta of 1.370, suggesting it is more volatile than the market.
